Blog
RSS FeedPosted by Michael Wonder on 22 Sep 2024
The impact of generic entry of pharmaceuticals in Australia
20 September 2024 - In this article, we estimate the initial and temporal impacts of generic entry on benchmark drug prices ...
Posted by Michael Wonder on 17 Jul 2022
Prescription medication prices to rise
15 July 2022 - The price of nearly 900 prescription medications will rise by as much as $7 on October ...
Posted by Michael Wonder on 21 Mar 2022
New Australian agency to accelerate genomic research and drive innovation in health care
21 March 2022 - Genomics advances will help develop revolutionary treatments for some of our biggest health challenges, including diagnosing ...
Posted by Michael Wonder on 19 Oct 2021
Strategies for generic/biosimilar market entry in Australia
19 October 2021 - After surviving the Great Patent Cliff of 2011–2016, the pharma/biopharma industry finds itself in the Second Great ...
Posted by Michael Wonder on 30 Apr 2020
Commonwealth fails in its claim for compensation for delayed PBS listing of generic clopidogrel
29 April 2020 - The decision highlights the inherent difficulty Courts face in cases involving claims on the Usual Undertaking. ...
Posted by Michael Wonder on 28 May 2018
ACCC loses appeal against Pfizer over Lipitor sales
25 May 2018 - A court has dismissed an Australian Competition and Consumer Commission appeal in a case in which ...
Posted by Michael Wonder on 02 Sep 2017
Commonwealth of Australia v Sanofi: hearing of Commonwealth's claim commences in Federal Court of Australia
31 August 2017 - A six-week hearing in the Federal Court of Australia commenced this week to decide whether the Commonwealth ...
Posted by Michael Wonder on 01 May 2017
Budget 2017: doctors reject changes on generic drugs which could save almost $2 billion
1 May 2017 - Australians will increasingly find themselves prescribed generic drugs rather than the big-name brands, under changes to ...
Posted by Michael Wonder on 21 Apr 2017
Patients will be pushed to use ‘generic drugs’ as medicine prices fall in the upcoming federal budget
21 April 2017 - Patients and taxpayers will pay less for hundreds of medicines as a result of the May ...
Posted by Michael Wonder on 29 Mar 2017
$30m damages for infringement of Bayer’s Australian Yasmin patent - a “small” jurisdiction with big benefits
29 March 2017 - In a recent landmark Australian Federal Court decision, Bayer v Generic Health FCA 250, Bayer was awarded ...
Posted by Michael Wonder on 25 Feb 2017
The importance of Swiss-style claims in Australia
24 February 2017 - The Federal Court has recently issued a decision that highlights the importance of including Swiss-style claims ...
Posted by Michael Wonder on 18 Feb 2017
When is applying for listing on the Pharmaceutical Benefits Scheme not an infringement?
16 February 2017 - In the most recent judgement in the Australian Lyrica litigation, Nicholas J has delivered an interesting decision ...
Posted by Michael Wonder on 19 Jan 2017
Generic Medicines Working Group – 1 December 2016
19 January 2017 - The communique for the Generic Medicines Working Group's 1 December meeting is now available. ...
Posted by Michael Wonder on 20 Sep 2016
Generic Medicines Working Group communique
20 September 2016 - The communique from the July 2016 meeting of the Generic Medicines Working Group is now available, ...
Posted by Michael Wonder on 31 Jul 2016
Schedule of Pharmaceutical Benefits - 1 August 2016 update
1 August 2016 - The August 2016 issue of the Schedule of Pharmaceutical Benefits is now available and in effect. ...